Skip to content
OpenCapital
Get started

McKesson MCK Enterprise value

Enterprise value at other companies

Eli Lilly logo
Eli LillyLLY
$859.77B+10.6%
Cardinal Health logo
Cardinal HealthCAH
$54.7B+45.4%
Cencora logo
CencoraCOR
$71.12B+20.6%
Viatris logo
ViatrisVTRS
$28.36B+17.7%
Medline, Inc. logo
Medline, Inc. MDLN
$46.44B—
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$58.42B-29.4%

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.9%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$91.3B+25.7%
P/E19.2×-2.9×
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp

Returns & leverage

See full
Return on equity36%—
Debt / equity2×—
Current ratio0.9×0.0×

Where this comes from

Calculated from McKesson’s reported figures.

$106.00Bmarket cap+$2.3Btotal debt−$4.0Bcash and equivalents=$104.3B

The official record: McKesson’s 10-K, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's enterprise value?
McKesson (MCK) reported enterprise value of $104.3B in Q1 2026.
How has McKesson's enterprise value changed year-over-year?
McKesson's enterprise value increased by 19.6% year-over-year, from $87.21B to $104.3B.
What is the long-term trend for McKesson's enterprise value?
Over 4 years (2022 to 2026), McKesson's enterprise value has grown at a 25.7% compound annual growth rate (CAGR), from $166.01B to $414.41B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.